HLN Haleon plc
$9.19▼ -0.33%
Healthcare
Other
After hours
$9.10▼ -0.98%
Sep 11, 5:05 PM ET
Volume 10.04M
Avg Volume (10D) 13.58M
Key Metrics & Fundamentals
Market Cap
$40.41B
P/E Ratio
18.8
Div Yield
2.14%
52W Range
8.65 - 11.28
% vs 50 MA
-6.74%
% vs 200 MA
-6.57%
RSI-14
29.3
MACD Histogram
-0.1100
Beta (1Y vs SPY)
-0.07
Gross Rev
$2.76B
Gross Profit
$1.53B
EBITDA
$362.00M
COGS
$1.23B
Operating Exp
$1.18B
Operating Income
$350.00M
EBIT
$350.00M
Pretax Income
$288.00M
Net Income
$231.00M
Price & Volume History
Loading chart…
Recent News
Walmart and Target’s Shelves are Becoming a Battleground for Budget-Conscious Shoppers
Insider Monkey · Sep 11, 2026 10:31 PM
LCUT or HLN: Which Is the Better Value Stock Right Now?
Zacks · Sep 11, 2026 3:40 PM
Deutsche Bank expects European consumer staples to underperform as structural pressures mount
Proactive · Sep 9, 2026 1:30 PM
Haleon And 2 British AI Healthcare Stocks To Watch
Simply Wall St. · Sep 5, 2026 10:15 AM
Sector Update: Healthcare Stocks Edge Higher Late Afternoon
MT Newswires · Sep 3, 2026 7:46 PM
Sector Update: Healthcare
MT Newswires · Sep 3, 2026 7:11 PM
Market Chatter: Haleon Negotiates Better Shelf Placement at Walmart, Target
MT Newswires · Sep 3, 2026 1:58 PM
Guinness owner drops responsible drinking targets from boss’s bonus
The Telegraph · Sep 1, 2026 12:41 PM
Reckitt Benckiser shares rise over 4% as JP Morgan upgrades to 'overweight'
Proactive · Sep 1, 2026 11:00 AM
Futura Medical advances Eroxon pipeline as it reshapes US commercial strategy
Proactive · Sep 1, 2026 6:23 AM
Financial Overview - Income Statement
Quarterly
Dec 2024
See HLN's money flow as a full page
Social Sentiment
No Reddit posts found for HLN.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.